Screener
Design Therapeutics, Inc. DSGN Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026. Open the filing →
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
FAQ
- What is Design Therapeutics, Inc.'s invested capital?
- Design Therapeutics, Inc. (DSGN) reported invested capital of $208.02M in Q1 2026.
- How has Design Therapeutics, Inc.'s invested capital changed year-over-year?
- Design Therapeutics, Inc.'s invested capital decreased by 3.9% year-over-year, from $216.39M to $208.02M.
- What is the long-term trend for Design Therapeutics, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s invested capital has grown at a 22.6% compound annual growth rate (CAGR), from $87.19M to $197.18M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Design Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude